Calviri Competitors and Similar CompaniesClear all
Calviri's competitors and similar companies include BioInvent, Inventiva, Therapeia and Isotopen Technologien Munchen.
 Calviri Calviri is a company that develops diagnostic and therapeutic products, as well as vaccines aimed to prevent cancer. |  Inventiva Inventiva is a clinical stage biopharmaceutical company with an expertise in fibrosis, oncology and orphan diseases. |  Therapeia Therapeia is a company that specializes in the development of diagnostic and therapeutic radiopharmaceuticals for unmet patient needs. |  Isotopen Technologien Munchen ITM Isotopen Technologien Munchen is a company that develops, produces, and supplies diagnostic and therapeutic radionuclides and radiopharmaceuticals for use in cancer treatment. | ||
Founding Date | Founding Date 2018 | Founding Date 1997 | Founding Date 2011 | Founding Date 2007 | Founding Date 2004 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Phoenix, US HQ | Locations Lund, SE HQ | Locations Daix, FR HQ | Locations Dresden, DE HQ | Locations Garching bei München, DE HQ München, DE |
Employees | Employees 16 | Employees 118 | Employees 114 | Employees N/A | Employees 5403% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 285.9 m | Valuation ($) 231 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) kr226.5m (FY, 2025) | Revenue (est.) €4.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit kr226.6m (FY, 2025) | Gross profit €7.9m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income (kr332.9m) (FY, 2025) | Net income (€354.1m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 2.3m (about 6 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 22m (about 10 years ago) |
Total funding raised | Total funding raised $ 2.3m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 22m |
For sources of this data, please see the company profile
View Company Profiles
BioInvent
HQ
Lund, SE
Employees
118
BioInvent focuses on the discovery and development of antibody-based drugs against cancer.
View companyInventiva
HQ
Daix, FR
Employees
114
Inventiva is a clinical stage biopharmaceutical company with an expertise in fibrosis, oncology and orphan diseases.
View companyTherapeia
HQ
Dresden, DE
Therapeia is a company that specializes in the development of diagnostic and therapeutic radiopharmaceuticals for unmet patient needs.
View companyIsotopen Technologien Munchen
HQ
Garching bei München, DE
Employees
540↑ 3% increase
ITM Isotopen Technologien Munchen is a company that develops, produces, and supplies diagnostic and therapeutic radionuclides and radiopharmaceuticals for use in cancer treatment.
View company